Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02528981Completed
Randomised, double-blind trial in Group B streptococcal colonization (GBS), sponsored by Toronto Metropolitan University. Primary endpoint: Group B Streptococcus colonization status at 12 weeks. Started Aug 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02528981.